Interactive Discussion on The First FDA Approved Anti-PDL1 Cancer Immunotherapy in Locally or Advanced Metastatic Urothelial Carcinoma

Event Details

• Start: 11 May 2017 7:00 pm EDT
• End: 11 May 2017 9:00 pm EDT